Analysis of the new and serious adverse drug reactions in our hospital from 2017 to 2021
10.3969/j.issn.1673-9701.2023.35.018
- VernacularTitle:某三甲医院2017～2021年新的和严重的药品不良反应分析
- Author:
Xiaolin FANG
1
;
Fei XIAO
Author Information
1. 安徽医科大学附属巢湖医院药物临床试验机构办,安徽合肥 238000
- Keywords:
Safe medicationg;
New adverse drug reactions;
Serious adverse drug reactions;
Report analysis
- From:
China Modern Doctor
2023;61(35):76-78,86
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the characteristics of the new and severe adverse drug reactions(ADR)in our hospital from 2017 to 2021,and to provide a reference for the rational use of drugs in the clinic and the reduction of ADR.Methods Retrospective classification and statistical methods were used to comprehensively analyze new and serious adverse drug reactions reported in our hospital.Results Among the 178 reports,the reporting staff was mainly pharmacists(163 cases,91.57%).Adverse reactions mainly occurred in patients over 65 years old(88 cases,49.44%).The dosage forms involved are mainly injections and tablets.Among the drugs involved,antitumor drugs accounted for the highest proportion(34.95%).ADR involved the most systemic/organ damage was hematological system(34.95%),followed by digestive system damage(29.03%).Conclusion Monitoring of new and serious ADR should be paid a close attention,especially antitumor drugs,to improve the reporting rate and ensure the safety of patients'medication.
